Story perspectives

Revolutionary Gene Therapy Offers Hope for Genetic Hearing Loss

9/16/2025

49 10

Summary

Story summary

Researchers at Tel Aviv University developed a gene therapy targeting the CLIC5 gene to treat genetic hearing loss.
This therapy preserves sensory cells in the inner ear, showing promise for congenital deafness in both children and adults.
A self-complementary AAV (scAAV) vector efficiently delivers the therapeutic gene, preventing hair cell degeneration.
The study maintains hearing and balance in animal models, indicating broader applications for various genetic hearing loss causes.
Prof. Karen Avraham led the research, supported by multiple scientific institutions.

1 of 1

Story summary

Researchers at Tel Aviv University developed a gene therapy targeting the CLIC5 gene to treat genetic hearing loss.
This therapy preserves sensory cells in the inner ear, showing promise for congenital deafness in both children and adults.
A self-complementary AAV (scAAV) vector efficiently delivers the therapeutic gene, preventing hair cell degeneration.
The study maintains hearing and balance in animal models, indicating broader applications for various genetic hearing loss causes.
Prof. Karen Avraham led the research, supported by multiple scientific institutions.